Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2021/22 group results

May 12 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           67.70           46.09          55.30        27.74    
               (+46.9 pct)     (+33.3 pct)    (-18.3 pct)  (-12.1 pct) 
  Operating       28.90           13.95          15.00         8.64    
              (+107.1 pct)    (+122.4 pct)    (-48.1 pct)  (-38.7 pct) 
  Recurring       28.46           14.16          15.10         8.73    
              (+101.0 pct)    (+123.1 pct)    (-46.9 pct)  (-38.7 pct) 
  Net
  Net             19.85            9.55          10.60         6.35    
              (+107.9 pct)    (+149.9 pct)    (-46.6 pct)  (-36.5 pct) 
  EPS          164.84 yen       79.29 yen      88.03 yen    52.77 yen  
  Ann Div       33.00 yen       16.00 yen      33.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       33.00 yen       16.00 yen      33.00 yen               
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news